Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Babjuk

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
European Urology|January 19, 2010
New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinomaMarko Babjuk
European Urology|May 26, 2024
Can an En Bloc Technique Improve Outcomes of Endoscopic Surgery for Non-muscle-invasive Bladder Cancer?Marko Babjuk
European Urology|April 10, 2024
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder CancerMarko Babjuk
European Urology|February 4, 2026
Re: Durvalumab in Combination with BCG for BCG-naive, High risk, Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 TrialMarko Babjuk
European Urology|November 5, 2018
Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-grade Non-muscle-invasive Bladder Cancer on Tumor RecurrenceMarko Babjuk
European Urology|May 8, 2020
Re: Multi-institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder CancerMarko Babjuk
European Urology|July 29, 2009
The search for the etiology of bladder cancer: are achievements sufficient?Marko Babjuk
European Urology|August 25, 2011
What are the limitations of endoscopic management of urothelial carcinoma of the upper urinary tract?Marko Babjuk
European Urology|February 2, 2022
Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder CancerMarko Babjuk
European Urology|May 12, 2020
Reply to Can Lu and Xiao Guan's Letter to the Editor re: Marko Babjuk. Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.01.022Marko Babjuk
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
European Urology|January 19, 2010
New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinomaMarko Babjuk
European Urology|May 26, 2024
Can an En Bloc Technique Improve Outcomes of Endoscopic Surgery for Non-muscle-invasive Bladder Cancer?Marko Babjuk
European Urology|April 10, 2024
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder CancerMarko Babjuk
European Urology|February 4, 2026
Re: Durvalumab in Combination with BCG for BCG-naive, High risk, Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 TrialMarko Babjuk
European Urology|November 5, 2018
Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-grade Non-muscle-invasive Bladder Cancer on Tumor RecurrenceMarko Babjuk
European Urology|May 8, 2020
Re: Multi-institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder CancerMarko Babjuk
European Urology|July 29, 2009
The search for the etiology of bladder cancer: are achievements sufficient?Marko Babjuk
European Urology|August 25, 2011
What are the limitations of endoscopic management of urothelial carcinoma of the upper urinary tract?Marko Babjuk
European Urology|February 2, 2022
Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder CancerMarko Babjuk
European Urology|May 12, 2020
Reply to Can Lu and Xiao Guan's Letter to the Editor re: Marko Babjuk. Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.01.022Marko Babjuk
Pageof 12